Arterial calcification is commonly seen in atherosclerosis, chronic kidney disease (CKD) and
diabetes and has long been considered a natural progression of atherosclerosis. Yet it is a …

Background People with end-stage kidney disease (ESKD) develop impaired excretion of
phosphate. Hyperphosphatemia develops in ESKD as a result of the kidney's reduced ability …

Free fatty acids (FFAs), elevated in metabolic syndrome and diabetes, play a crucial role in
the development of atherosclerotic cardiovascular disease, and eicosapentaenoic acid …

Aim: The ankle brachial index (ABI) is a marker for peripheral artery disease and can predict
mortality in advanced chronic kidney disease (CKD) and haemodialysis patients …

Aim To evaluate the effectiveness of a bundled self‐management intervention (taking control
of your phosphate with the 4Ds) to improve phosphate control among adults receiving …

Recent studies have highlighted a significant association between the severity of
atherosclerosis and bone mineral density (BMD) among healthy subjects, although its …

Atheroma calcification is a common feature of advanced atherosclerosis, however with the
advent of CT scanning it has become possible to detect extensive coronary calcification in …

Objective: Arterial stiffness refers to arterial wall rigidity, particularly developing in central
vessels. Arterial stiffness increases in early stage chronic kidney disease (CKD), and it is a …

Vascular calcifications represent a severe complication of secondary hyperparathyroidism in
patients with chronic kidney disease (CKD) stage 5. The factors influencing the development …

Abstract Fetuin-A (α2Heremans-Schmid glycoprotein) is a glycoprotein which is synthesized
in the liver and secreted into the bloodstream. It belongs to a large group of binding proteins …